A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
Clinical trial NCT01709760 · UNKNOWN
Trial details
- NCT number
- NCT01709760
- Sponsor
- Mycenax Biotech Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.